Rancho BioSciences
↗San Diego, USA
Rancho BioSciences is a global scientific data company that provides data science services and products to the life sciences and healthcare sectors. The company specializes in transforming complex, disparate biomedical data into trusted, interoperable, and AI-ready intelligence to accelerate drug discovery, translational research, and clinical development.
Their core capabilities include data curation, data governance, bioinformatics analysis, scientific data engineering, and the development of predictive, multimodal AI models. Rancho BioSciences operates as a partner to pharmaceutical, biotech, and research organizations, helping them bridge the gap between scientific expertise and data technology.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$5M-$10M
Founded:2012
Ownership:subsidiary
Status:acquired
FUNDING
Total Raised:$0
PIPELINE
Modalities:Small molecule, Genomics, Proteomics, Single-cell sequencing
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Arsenal Capital Partners
Acquired By:Arsenal Capital Partners (2025-03-01)
Key Partnerships:ONTOFORCE (Knowledge discovery collaboration), Sapient (Multiomics database expansion), NCATS (Development of SEQUIN app)
COMPETITION
Position:Niche Player
Competitors:Evotec, Benchling, Helix
LEADERSHIP
Key Executives:
Julie Bryant - Founder and CEO
Scientific Founders:Julie Bryant
LINKS
Website:ranchobiosciences.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Rancho BioSciences and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Rancho BioSciences. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.